(Q34923189)

5 August 2017

1 reference

title

Review of L-tyrosine confirming its safe human use as an adjuvant (English)

1 reference

5 August 2017

Paul Baldrick

1

1 reference

5 August 2017

Derek Richardson

series ordinal

2

1 reference

5 August 2017

Alan W Wheeler

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Journal of Applied Toxicology

5 August 2017

published in

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

333-344

1 reference

Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL) adjuvant: a new allergy vaccine for dust mite allergy

5 August 2017

cites work

1 reference

CNS effects in the correct perspective

21 January 2018

1 reference

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

21 January 2018

1 reference

Clinical and immunologic evaluation of glutaraldehyde-modified tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Advances in vaccine adjuvants

21 January 2018

1 reference

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

21 January 2018

1 reference

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

21 January 2018

1 reference

A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JAT.869

1 reference

5 August 2017

1 reference